Technology & ScienceNVIDIA Locks Eli Lilly and Thermo Fisher Into AI Drug Discovery Platform as Pharma R&D Goes StructuralSalvado•Jun 1, 2026
Business & FinanceEli Lilly Crosses $20B in 2026 Acquisitions as AI Rewrites Pharma's Global Deal LogicSalvado•May 31, 2026
Health & ScienceNVIDIA Locks Global Pharma Into AI Drug Discovery as Novo Nordisk Surges 24.9%Salvado•May 31, 2026
Health & Pharma TechNVIDIA Locks Lilly and Thermo Fisher Into BioNeMo as Global Drug Discovery Platform Race IntensifiesSalvado•May 27, 2026
Health & BiotechNVIDIA's BioNeMo Becomes Global Pharma Infrastructure as Novo Nordisk, Eli Lilly Rebuild R&D Around AISalvado•May 18, 2026
Health & ScienceNVIDIA's BioNeMo Becomes Global Drug Discovery Infrastructure as Eli Lilly and Thermo Fisher Join PlatformSalvado•May 16, 2026
Technology & ScienceNVIDIA Locks In Eli Lilly and Thermo Fisher as BioNeMo Becomes Global Pharma AI BackboneSalvado•May 1, 2026
Technology & InnovationNVIDIA Secures Thermo Fisher and Eli Lilly as Global Biotech AI Platform Race IntensifiesSalvado•Apr 29, 2026
Healthcare TechnologyNVIDIA Secures Eli Lilly and Thermo Fisher for BioNeMo Drug Discovery Platform as Pharma AI Infrastructure ConsolidatesSalvado•Apr 17, 2026
Health & MedicineNVIDIA's BioNeMo Platform Reaches Eli Lilly and Thermo Fisher in Global Pharma AI PushSalvado•Apr 13, 2026
AI & TechnologyNVIDIA Locks Down Global Pharma AI Infrastructure Through Eli Lilly, Thermo Fisher Platform DealsSalvado•Apr 11, 2026
biotechnologyNVIDIA BioNeMo Secures Eli Lilly and Thermo Fisher as Platform Wars Erupt in Global Pharma AISalvado•Apr 9, 2026
Healthcare AINVIDIA BioNeMo Platform Secures Eli Lilly and Thermo Fisher Partnerships for AI Drug Discovery InfrastructureSalvado•Mar 26, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Adopted by Eli Lilly and Thermo Fisher for AI Drug DiscoverySalvado•Mar 23, 2026
